Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/1995
11/29/1995EP0683781A1 Novel inhibitors of adenosine monophosphate deaminase
11/29/1995EP0540560B1 Ancrod-like proteins, their preparation and their use
11/29/1995EP0495047B1 Stable hemoglobin based composition and method to store same
11/29/1995CN1112560A Piperidine derivatives and anti-platelet agents containing the same
11/28/1995US5470965 Complexable heterogenous oligosaccharides and alpha-hydosanes having therapeutical activity, process for their preparation and related pharmaceutical compositions
11/28/1995US5470855 Certain heterocyclic thiazole derivatives and their therapeutic use
11/28/1995US5470849 Anticoagulants
11/28/1995US5470841 Metabolizable plasma substitute
11/28/1995US5470738 Diagnostic systems for assaying platelets in a vascular fluid
11/28/1995CA2150327A1 Pharmaceutical preparation for the prevention and treatment of blood coagulation disorders
11/23/1995WO1995031536A1 Process for producing thrombin
11/23/1995WO1995031482A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995WO1995031467A1 Monocyte chemotactic protein-4
11/23/1995CA2190454A1 Process for producing thrombin
11/23/1995CA2190262A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/22/1995EP0683173A1 Cyclic adhesion inhibitors
11/22/1995CN1112104A Acetic acid derivatives
11/21/1995US5468757 For treating stroke or myocardial infarction in humans
11/16/1995WO1995030641A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
11/15/1995EP0682026A1 "Stable crystalline (6S)- and (6R)-tetrahydrofolic acid"
11/15/1995EP0682015A1 Piperidine derivates and anti-platelet agents containing the same
11/15/1995EP0681840A1 Use of phosphate diester for the treatment of retinal diseases
11/15/1995EP0681833A2 Nasally administrable compositions
11/15/1995EP0681590A1 Anticoagulant composition
11/15/1995EP0681589A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
11/15/1995CN1111630A Adhesion receptor antagonists
11/15/1995CN1111508A Fatty acid derivatives
11/15/1995CN1030251C Substituted 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives
11/14/1995US5466829 Platelet aggregation inhibiting effect
11/14/1995US5466826 Process for preparing a physical form of pharmaceutical agent
11/11/1995CA2147587A1 Method and composition for prophylaxis and treatment of retinal diseases
11/08/1995EP0680764A2 Stable preparation for the treatment of blood coagulation disorders, comprising an activated coagulation factor and lipid vesicles
11/08/1995EP0680763A2 Stable preparation for the treatment of blood coagulation disorders comprising an activated coagulation factor and lipid vesicles
11/08/1995EP0680478A1 N,N'-CYCLOALKYL/ALKYL CARBOXAMIDE 4H-IMIDAZO 4,5-b]PYRIDINE COMPOUNDS AS PAF ANTAGONISTS
11/08/1995EP0680468A1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation
11/08/1995EP0680346A1 Method of increasing the concentration of nitric oxide in blood
11/08/1995EP0412149B1 Use of il-7 in providing medications for stimulation of platelet production
11/08/1995EP0393051B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
11/07/1995US5464935 Peptide inhibitors of selectin binding
11/07/1995US5464845 Methods for lowering serum cholesterol
11/07/1995US5464788 Tocolytic oxytocin receptor antagonists
11/07/1995US5464634 Red blood cell surrogate
11/07/1995CA2148746A1 Stable preparation for the treatment of blood coagulation disorders
11/07/1995CA2148672A1 Stable preparation for the treatment of blood coagulation disorders comprising an active coagulation promoting substance
11/07/1995CA1337517C Use of dextrin derivatives for the treatment of acidic conditions
11/02/1995WO1995029259A1 Method and means for detecting and treating disorders in the blood coagulation cascade
11/02/1995WO1995029189A1 FACTOR Xa INHIBITORS
11/02/1995WO1995028954A1 Formulations for factor ix
11/02/1995WO1995028915A1 Red blood cell surrogate
11/02/1995CA2177066A1 Red blood cell surrogate
11/01/1995CN1111058A Inhibitor of collagen-stimulated platelet aggregation
11/01/1995CN1110968A Substituted N-piperidino-pyrazole-3-carboxamide
10/1995
10/31/1995US5463564 System and method of automatically generating chemical compounds with desired properties
10/31/1995US5463087 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments
10/31/1995US5463071 Tetrazole derivatives; useful for inhibiting undesirable cell aggregation
10/31/1995US5463025 Protein having human plasmin inhibiting activity
10/31/1995US5462950 Administering raloxifene or salt
10/31/1995US5462941 1-(cyclohexylalkylamino)-4-(phenyl, thienyl, or furyl) phthalazines; anti-platelet agglutination agents for treatment or prevention of cerebro- or cardiovascular disorders
10/31/1995US5462925 Transforming growth factor β2,3
10/31/1995CA2042398C Orally administered porphyrins to control intestinal iron absorption
10/26/1995WO1995028480A1 Methods of use of uncoated gel particles
10/26/1995WO1995028420A1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
10/26/1995CA2188162A1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
10/26/1995CA2187526A1 Methods of use of uncoated gel particles
10/25/1995EP0678507A1 Method for preparing homochiral maleimide intermediates, via silylation techniques, used in the enantioselective preparation of anti-thrombotic and anti-vasospastic compounds
10/25/1995EP0678495A2 Process for the purification of perfluoroalkylbromides or perfluoroalkylene dibromides
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/24/1995US5460953 Vectors and compounds for expression of glycosylation mutants of human protein C
10/24/1995CA1337407C Dimeric peptides having a stimulatory effect on haemopoiesis and a process for their preparation
10/21/1995CA2147429A1 Piperidine derivatives and anti-platelet agents containing the same
10/21/1995CA2147343A1 Process for the purification of perfluoroalkyl bromides or perfluoroalkylene dibromides
10/21/1995CA2146038A1 Method for preparing homochiral maleimide intermediates, via silylation techniques, used in the enantioselective preparation of anti-thrombotic and anti-vasospastic compounds
10/19/1995WO1995027496A1 Vasoactive intestinal polypeptide
10/19/1995WO1994028145A3 Expression of urokinase plasminogen activator inhibitors
10/19/1995CA2187322A1 Vasoactive intestinal polypeptide
10/18/1995EP0677531A1 Derivates of boronic peptides, preparation and use thereof in therapy
10/18/1995EP0677291A2 Composition and method containing optically pure (S) metoprolol
10/18/1995EP0677107A1 Clotting inhibitor made from protostomia saliva.
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677043A1 Platelet aggregation inhibiting compounds
10/18/1995EP0677041A1 Chemical compounds
10/18/1995EP0677039A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
10/18/1995EP0676955A1 Red blood cell surrogate
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110174A Compound medicine for curing hemophilia and producing technology thereof
10/18/1995CN1110172A Compound preparation for curing nutritional iron-deficiency anemia
10/17/1995US5459152 Platelet activating factor antagonists
10/13/1995CA2146833A1 Boronic peptides derivatives; process for preparing the same and their use as therapeutic agents
10/12/1995WO1995027062A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995WO1995027053A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY
10/12/1995WO1995026750A1 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
10/12/1995WO1995026746A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/12/1995WO1995026737A1 Use of biopolymers for digestive tract injuries treatment
10/12/1995WO1995025091A3 Nipecotic acid derivatives as antithrombic compounds
10/12/1995CA2186635A1 .alpha.-1-antichymotrypsin analogues having chymase inhibiting activity
10/12/1995CA2185211A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/11/1995EP0676470A1 Stem cell factor
10/11/1995EP0676207A2 Anticomplementary agent prepared from fucans of brown seaweed
10/11/1995EP0675956A1 New protein from urine named component b
10/11/1995EP0675899A1 NOVEL INHIBITORS OF FACTOR Xa
1 ... 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 ... 671